Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Correction to "Developing Metal Complexes for Captopril Quantification in Tablets Using Potentiometric and Conductometric Methods". [PDF]
Al-Farhan BS +4 more
europepmc +1 more source
Survivin and Aurora Kinase A control cell fate decisions during mitosis
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir +2 more
wiley +1 more source
Weaving science and traditional knowledge: Toward sustainable solutions for ocean management
Mariana Caldeira +2 more
openalex +1 more source
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir +12 more
wiley +1 more source
Large Language Models in Computer Science Classrooms: Ethical Challenges and Strategic Solutions
Rina Azoulay +2 more
openalex +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Letter to the Editor on "Adjunctive interventions: change methods directed at recipients that support uptake and use of health innovations." (Smith JD, Li DH, Merle, JL et al. adjunctive interventions: change methods directed at recipients that support uptake and use of health innovations. Implementation Sci 2024;19:10. Doi:10.1186/s13012-024-01345-z). [PDF]
Lederer LG, Buchanan G.
europepmc +1 more source

